Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device
NCT04116827 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2019-10-07
Summary
The aim of this study is to observe the sleep and activity patterns of pre-menopausal breast cancer patients taking tamoxifen using a wrist-worn internet of things device and questionnaires.
Conditions
- Sleep Disorder
- Breast Cancer
Interventions
- DRUG
-
Tamoxifen Oral Tablet
Patients who are scheduled for application of tamoxifen and goserelin
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-10
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer
NCT03351062 ·Status: RECRUITING ·Phase: PHASE3
-
Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+
NCT01220076 ·Status: COMPLETED ·Phase: PHASE2
-
SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer
NCT00929591 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer
NCT03045653 ·Status: COMPLETED ·Phase: PHASE2
-
Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients
NCT03931928 ·Status: COMPLETED ·Phase: PHASE2
-
Tamoxifen Pharmacogenetics in Asian Breast Cancer Women
NCT01181518 ·Status: UNKNOWN
-
Pilot Study About Tamoxifen Therapy for Breast Cancer Patients
NCT02094495 ·Status: UNKNOWN
-
Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up
NCT01357772 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
NCT00096369 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast Cancer
NCT00086749 ·Status: COMPLETED
-
Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer
NCT00005605 ·Status: COMPLETED
-
Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients
NCT02132000 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients
NCT01169792 ·Status: COMPLETED
-
Neoadjuvant Tamoxifen in Locally Advanced Breast Cancer in a Low/Middle Income Country
NCT02806544 ·Status: COMPLETED ·Phase: PHASE2
-
Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen
NCT00764322 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376
NCT04961632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer
NCT00899197 ·Status: TERMINATED
-
Collaborative Research: Multiscale Modeling and Intervention for Improving Long-Term Medication
NCT06865755 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
CYP2D6 Genotype on the Clinical Effect of Tamoxifen
NCT00973037 ·Status: UNKNOWN
-
Preoperative Window of Endocrine Therapy Provides Information to Increase Compliance
NCT01614210 ·Status: COMPLETED ·Phase: PHASE2
-
Melatonin as Adjuvant Therapy in Breast Cancer Patients
NCT01557478 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Decision Aids for Tamoxifen Treatment in Breast Cancer Patients
NCT02488603 ·Status: UNKNOWN ·Phase: NA
-
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
NCT06033092 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Tamoxifen in Treating Women With High-Risk Breast Cancer
NCT00002542 ·Status: COMPLETED ·Phase: PHASE3
-
Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer
NCT00002581 ·Status: COMPLETED ·Phase: PHASE3